The Daily Caller cites CEI`s Greg Conko on Gilead Sciences` new Hepatitis C pill:
Instead of enduring up to a year of weekly injections, patients can simply take one or two pills a day for eight to 12 weeks and almost always rid themselves of the disease for good, experiencing minimal side effects in the process.
Still, Gilead shocked the medical world when it announced the $84,000 price tag for a 12-week supply of Sovaldi, which must be taken in combination with a different drug; or $94,000 price tag for a 12-week supply of Harvoni, which can be taken alone.
“It’s more effective; it’s safer; it’s cheaper,” Greg Conko, executive director of the Competitive Enterprise Institute, told TheDCNF. “You would think that people would want to throw Gilead a party. What they did was chastise them.”